Cancer Detect Profiles

Every cancer is different, just as every patient is different. Our genomic assessment test helps to identify DNA alterations. These mutations can contribute to particular tumor. Early detection allows targeting the specific tumor’s genomic profile.

Our cancer genomics testing analyzes a patient’s DNA to find out any mutations that might increase the risk of hereditary cancer. Comprehensive detection report indicates a patient’s potential susceptibility to various hereditary cancers using the latest sequencing technique. This next-generation sequencing technology allows for accurate and rapid results.

The information retrieved from this testing technique can help a clinician to develop a personalized therapy after studying your genomic mutation.

Our cancer genomics testing analyses a total of 37 genes. With the help of this test, over 18 different cancers can be detected.

Your oncologist will determine whether you are a candidate for cancer detection test or not. Remember, every patient isn’t the right candidate for genomic testing.

Additional Services

Evolution of cancer testing

Scientists have been looking to improve ways to detect and treat cancer. Radiation therapy and chemotherapy showed a lot of promise but both these treatments had their own drawbacks. Unfortunately, chemotherapy fails to distinguish between cancer cells and normal cells and therefore results in side effects. Similarly, radiation therapy in its early days failed to treat cancer completely as later tests showed the presence of cancer cells after successful therapy.

In the past decade, medical research has contributed a great deal to improve these therapies. Today, they are more targeted than ever with minimal side effects. As a result, radiation and chemotherapy have helped millions of cancer patients live longer.

The Human Genome Project and the future of cancer treatments

Although these therapies have come a long way, they still have their side effects and limitations. For example, two patients may display similar symptoms and imaging results and receive the same chemotherapy regimen. However, it may show very different results for both patients because of different molecular makeup.

The solution to this problem was solved by the Human Genome Project. This project, completed in 2003, allowed researchers to map the human genome. As a result, researchers were able to link various diseases to the genetic code including colon cancer and Alzheimer’s disease.

With the help of this technology, scientists have discovered that genes named BRCA1 and BRCA2 are associated with ovarian and colon cancer. With these discoveries, researchers have developed treatments for breast cancer that regulate the production of HER2 protein.

These drugs developed from genome research are standard treatments for various cancers including ovarian, breasts, and lungs cancer. They target genetic abnormalities by detecting mutations.